These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19251401)

  • 1. Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
    Smith RC; Lindenmayer JP; Davis JM; Cornwell J; Noth K; Gupta S; Sershen H; Lajtha A
    Schizophr Res; 2009 May; 110(1-3):149-55. PubMed ID: 19251401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
    Hong LE; Thaker GK; McMahon RP; Summerfelt A; Rachbeisel J; Fuller RL; Wonodi I; Buchanan RW; Myers C; Heishman SJ; Yang J; Nye A
    Arch Gen Psychiatry; 2011 Dec; 68(12):1195-206. PubMed ID: 21810630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia.
    Liu ME; Tsai SJ; Jeang SY; Peng SL; Wu SL; Chen MC; Tsai YL; Yang ST
    Psychiatry Res; 2011 Nov; 190(1):79-84. PubMed ID: 21636135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
    Smith RC; Amiaz R; Si TM; Maayan L; Jin H; Boules S; Sershen H; Li C; Ren J; Liu Y; Youseff M; Lajtha A; Guidotti A; Weiser M; Davis JM
    PLoS One; 2016; 11(1):e0143490. PubMed ID: 26730716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varenicline modulates spatial working memory deficits in smokers with schizophrenia.
    Wing VC; Wass CE; Bacher I; Rabin RA; George TP
    Schizophr Res; 2013 Sep; 149(1-3):190-1. PubMed ID: 23849883
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study.
    Fatemi SH; Yousefi MK; Kneeland RE; Liesch SB; Folsom TD; Thuras PD
    Schizophr Res; 2013 May; 146(1-3):376-8. PubMed ID: 23507358
    [No Abstract]   [Full Text] [Related]  

  • 8. Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
    Cerimele JM; Durango A
    J Clin Psychiatry; 2012 Aug; 73(8):e1039-47. PubMed ID: 22967780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy.
    Cather C; Hoeppner S; Pachas G; Pratt S; Achtyes E; Cieslak KM; Evins AE
    J Dual Diagn; 2017; 13(3):168-178. PubMed ID: 28414583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia.
    Roh S; Hoeppner SS; Schoenfeld D; Fullerton CA; Stoeckel LE; Evins AE
    Psychopharmacology (Berl); 2014 Feb; 231(4):765-75. PubMed ID: 24114425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia.
    Smith RC; Singh A; Infante M; Khandat A; Kloos A
    Neuropsychopharmacology; 2002 Sep; 27(3):479-97. PubMed ID: 12225705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial.
    Shim JC; Jung DU; Jung SS; Seo YS; Cho DM; Lee JH; Lee SW; Kong BG; Kang JW; Oh MK; Kim SD; McMahon RP; Kelly DL
    Neuropsychopharmacology; 2012 Feb; 37(3):660-8. PubMed ID: 22048460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful smoking cessation and improvement of negative symptoms with varenicline in a stable schizophrenia patient.
    Anghelescu I
    J Neuropsychiatry Clin Neurosci; 2009; 21(1):102-3. PubMed ID: 19359464
    [No Abstract]   [Full Text] [Related]  

  • 15. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nicotine nasal spray on cognitive function in schizophrenia.
    Smith RC; Warner-Cohen J; Matute M; Butler E; Kelly E; Vaidhyanathaswamy S; Khan A
    Neuropsychopharmacology; 2006 Mar; 31(3):637-43. PubMed ID: 16160711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity.
    Dutra SJ; Stoeckel LE; Carlini SV; Pizzagalli DA; Evins AE
    Psychopharmacology (Berl); 2012 Jan; 219(1):25-34. PubMed ID: 21695488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
    Smith RC; Jin H; Li C; Bark N; Shekhar A; Dwivedi S; Mortiere C; Lohr J; Hu Q; Davis JM
    Schizophr Res; 2013 Jan; 143(1):18-24. PubMed ID: 23200554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.